The Report Guru

The projected trajectory of the global minimally invasive surgical instruments market depicts a robust growth scenario, with estimations foreseeing a monumental USD 28,902.2 million by 2026, representing a commendable compound annual growth rate (CAGR) of 7.4% during the forecast period. This exponential growth is underpinned by various drivers, opportunities, while grappling with certain restraints and challenges inherent to the industry. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Advantages of MIS over conventional open surgical techniques stand as a prominent driver propelling market expansion. The transformative advancements in MIS technologies, exemplified by techniques like laparo-endo single-incision surgery (LESS), offer a myriad of advantages including minimal scarring, reduced recovery periods, and lower healthcare costs. The growing acceptance of MIS by patients, buoyed by favorable insurance coverage in select regions, ...

According to research report the global minimally invasive surgical instruments market is projected to reach USD 28.9 billion by 2026 from USD 20.2 billion in 2021, at a CAGR of 7.4% during the forecast period. Growth in this market is mainly driven by factors such as the increasing number of surgical procedures worldwide, the advantages of MIS over open surgical techniques, and the increasing adoption of advanced robotics in ASCs. However, the high degree of market consolidation among market players and the requirement of high capital investments are the major factors hampering the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Opportunities: Increasing adoption of advanced robotics in ASCs Ambulatory surgery centers (ASCs) are freestanding facilities specializing in surgical, diagnostic, and preventive procedures that do not require hospital admission. The cost-effectiveness of ASCs provides significant savings ...

The global minimally invasive surgical instruments market is projected to reach USD 28.9 billion by 2026 from USD 20.2 billion in 2021, at a CAGR of 7.4% during the forecast period. Growth in this market is mainly driven by factors such as the increasing number of surgical procedures worldwide, the advantages of MIS over open surgical techniques, and the increasing adoption of advanced robotics in ASCs. However, the high degree of market consolidation among market players and the requirement of high capital investments are the major factors hampering the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 The key players in this market are Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), Boston Scientific Corporation (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Smith & Nephew plc (UK), Surgical Innovations Group plc (UK), Koninklijke ...

The field of healthcare is in a constant state of evolution, and one of the most significant advancements in recent times has been the rise of minimally invasive surgical procedures. These procedures have not only revolutionized patient experiences but have also driven the growth of the global minimally invasive surgical instruments market . With the market projected to reach a staggering USD 28,902.2 million by 2026, growing at a robust CAGR of 7.4% during the forecast period, it's evident that the era of minimally invasive surgery is here to stay. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Minimally invasive surgical techniques have garnered immense popularity due to their ability to address surgical needs with fewer complications and shorter recovery times compared to traditional open surgeries. This shift in approach is particularly notable considering the surge in surgical procedures witnessed across the globe. As medical in...

  Minimally invasive surgical instruments industry revolution Minimally invasive surgical instruments are a major advancement in modern medical technology. These instruments allow surgeons to perform complex procedures without having to make large incisions. This means that patients can often experience shorter hospital stays, fewer complications, and less post-operative pain. The minimally invasive surgical instruments industry is highly competitive, with many different manufacturers competing for market share. These manufacturers are constantly looking for ways to improve their products, such as developing new materials and technologies. For example, some instruments are now made from carbon fiber or titanium, which can be more precise and flexible than traditional steel instruments. The industry is also increasingly focused on the development of robotic instruments. These robots can be programmed to perform precise movements, allowing surgeons to make smaller inci...

The global minimally invasive surgical instruments market is projected to reach USD 28.9 billion by 2026 from USD 20.2 billion in 2021, at a CAGR of 7.4% during the forecast period. Growth in this market is mainly driven by factors such as the increasing number of surgical procedures worldwide, the advantages of MIS over open surgical techniques, and the increasing adoption of advanced robotics in ASCs. However, the high degree of market consolidation among market players and the requirement of high capital investments are the major factors hampering the growth of this market. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 The key players in this market are Medtronic plc (Ireland), Johnson Johnson (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), Boston Scientific Corporation (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Smith Nephew plc (UK), Zimmer Biomet Holdings, Inc. (US), Becton, Dickinson and Comp...

The advantages of MIS over open surgical techniques, the increasing adoption of advanced robotics in ASCs, and the increasing number of surgical procedures worldwide are the major factors driving the minimally invasive surgical instruments market growth. According to latest research report the global minimally invasive surgical instruments market size is projected to reach USD 28.9 billion by 2026 from USD 20.2 billion in 2021, at a CAGR of 7.4% during the forecast period Based on product, the minimally invasive surgical instruments market is segmented into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical electrocautery instruments, and other instruments. In 2020, the handheld instruments accounted for the largest share of the MIS instruments market. The large share of this segment can mainly be attributed to factors such as the increasing number of surgical procedures, the low cost of articulating laparoscopic ...

According to the new market research report Minimally Invasive Surgical Instruments Market by Product (Handheld Instruments, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestinal), End User (Hospitals, Ambulatory Surgery Centers and Clinic) - Global Forecast to 2025, published by MarketsandMarkets™, the Minimally Invasive Surgical Instruments Market is projected to reach USD 32.7 billion by 2025 from USD 20.1 billion in 2019, at a CAGR of 8.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Market growth is largely driven by factors such as the advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe. However, the uncertain regulatory framework in the medical device industry is a major factor restraining the growth of this market during the forecast period. Handheld instruments accounted for the largest...

 According to the new market research report " Minimally Invasive Surgical Instruments Market by Product (Handheld Instruments, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestinal), End User (Hospitals, Ambulatory Surgery Centers and Clinic) - Global Forecast to 2025", published by MarketsandMarkets™, the Minimally Invasive Surgical Instruments Market is projected to reach USD 32.7 billion by 2025 from USD 20.1 billion in 2019, at a CAGR of 8.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Market growth is largely driven by factors such as the advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe. However, the uncertain regulatory framework in the medical device industry is a major factor restraining the growth of this market during the forecast period. Handheld instruments accounted f...

  Market growth is largely driven by factors such as the advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures performed across the globe. On the other hand, the uncertain regulatory framework in the medical device industry is a major factor restraining the growth of this market. According to research report the global minimally invasive surgical instruments market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 The major players in the Minimally Invasive Surgical instruments market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Smith & Nephew plc (US), Boston Scientific Corporation (US), and CONMED Corporation (US). These players have adopted v...

The on-going COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic. At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Minimally Invasive Surgical Instruments Market. We are working diligently to help companies take rapid decisions by studying: The impact of COVID-19 on the Minimally Invasive Surgical Instruments Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market The rapid shifts in the strategies of the Top 50 companies in the Minimally Invasive Surgical Instruments Market The shifting short-term priorities of the top 50 companies’ clients and their client's clients You can request an in-depth analysis detailing the imp...

According to research report Minimally Invasive Surgical Instruments Market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5%. The advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe are the key factors driving market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 Handheld instruments accounted for the largest share of the global MIS instruments market in 2018. Based on product, the MIS instruments market is segmented into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical & electrocautery instruments, and other instruments. Handheld instruments accounted for the largest share of the MIS instruments market in 2018, owing to factors such as the increasing number of surgical procedures and the development of high-d...

Benefits of minimally invasive surgeries over traditional open surgeries; reduction in healthcare costs and time; increasing number of surgeries among the aging population; increasing prevalence of lifestyle disorders; and technological advancements are key factors driving market growth for minimally invasive surgical instruments. Market Overview - According to the new market research report  Minimally Invasive Surgical Instruments Market  is projected to reach USD 21.47 Billion by 2021 from USD 13.89 Billion in 2016, at a CAGR of 9.1%. Asia-Pacific is expected to grow at the highest rate. With rising geriatric population, presence of a large patient pool undergoing surgical treatments, growing awareness about modern surgical instruments and techniques, and implementation of various initiatives to reduce the rising healthcare expenditure in Asia-Pacific, the demand for minimally invasive surgical instruments in this region is expected to grow, which in turn will compel the ke...